Amazon (AMZN) reportedly forecasts a USD 612mln gross loss for its devices business this year (vs. internal target of USD 438mln loss), as surging memory chip costs squeeze margins, Business Insider reports, citing an internal document
Newsquawk Staff ·
Amazon (AMZN) reportedly forecasts a USD 612mln gross loss for its devices business this year (vs. internal target of USD 438mln loss), as surging memory chip costs squeeze margins, Business Insider reports, citing an internal document.
What it means
Leaks of internal divisional targets ahead of a print follow a familiar pattern for large-cap tech: the device unit at this company has long been run as a loss-making funnel for its services and advertising ecosystem, so a widening loss there has historically been tolerated provided the high-margin segments absorb it. The transmission channel worth isolating is input cost rather than demand: surging memory pricing is a component cycle story, and episodes of sharp DRAM and NAND cost inflation have tended to compress hardware margins across the whole device and consumer electronics peer set, not just one issuer, which is how read-across to suppliers and rivals typically forms. The gap between the internal target and the forecast matters more than the absolute number, since it signals procurement assumptions made earlier in the cycle are now stale. What bears watching is whether management addresses component cost pass-through on the next earnings call and whether the loss is framed as temporary input inflation or as a structural reset of the hardware strategy. As a single-document leak rather than guidance, the figures carry attribution risk and are liable to revision.
Sources
- Meta (META) notes pricing of 250 mln Series A Depositary Shares at public offering price of USD 50 per Depositary Share
- US Market Wrap: Stocks gain as AI bounces ahead of key macro risk events
- Broadcom (AVGO) says a new special purpose vehicle will purchase Broadcom XPU AI accelerators and networking solutions for Anthropic; deliveries expected to start in 2027
- Cadence Design Systems Inc. (CDNS) Q3 2026 (USD): Adj. EPS 2.11 (exp. 2.05), Revenue 1.63bln (exp. 1.61bln)
- Moderna (MRNA) CEO says the melanoma vaccine will work in more cancers
Related headlines
- OpenAI launches Chat GPT 6.1 Terra15 hours ago
- Apple (AAPL) says aware of issue on small number of iPhone duos, affecting inner display of iPhone Duo16 hours ago
- Newsquawk Daily US Conference Calendar - 27th October 2026: TMO, BMY, GEV16 hours ago
- Apple (AAPL) iPhone Duo draws early complaints of the screen cracking16 hours ago
- Microsoft (MSFT) to offer buyouts to 60k workers in latest cost-cut, reports Bloomberg TV17 hours ago
- US EQUITY OPEN: Indices in the green as risk events await19 hours ago
- Nucor Corporation (NUE) Q3 2026 (USD): EPS 5.80 (exp. 5.71), Sales 11.3bln (exp. 10.8bln)12 hours ago
- Welltower Inc. (WELL) Q3 2026 (USD) Adj. FFO/Shr 1.67 (exp. 1.37), Revenue 3.72bln (exp. 3.64bln)13 hours ago
- Public Storage (PSA) Q3 2026 (USD): EPS 1.69 (exp. 2.49), Revenue 1.37bln (exp. 1.34bln)13 hours ago
- US judge lets Eli Lilly (LLY) continue weight-loss drug ads, ruling against Novo Nordisk (NOVOB DC)13 hours ago
- Truist (TFC) reportedly considers sale of AFCO14 hours ago
- FTC and 20 states sue Dollar General (DG), alleging years of deceptive pricing practices that charged customers more at checkout than the advertised shelf prices and cost consumers millions16 hours ago
- FHFA Director Pulte says we are taking more action this week in the credit scoring industry to ensure competition is real and not fake, or manipulated17 hours ago
- Merck’s (MRK) Keytruda as monotherapy reduced the risk of disease progression or death by 43% vs chemotherapy for certain patients with advanced or recurrent endometrial cancer with mismatch repair deficient tumours17 hours ago
- Bank of America (BAC) shares are reportedly firmer amid positive mentions in an M&A blog - UNCONFIRMED18 hours ago